Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Lannett Mixed Amphetamine Salts 10mg Recalled for Foreign Tablet Presence

Agency Publication Date: September 9, 2025
Share:
Sign in to monitor this recall

Summary

Lannett Company Inc. is recalling 4,848 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Amphetamine Salts) 10mg tablets. The recall was initiated because two bottles labeled as 10mg tablets were found to contain a single 5mg tablet of the same medication. This packaging error could lead to a patient receiving a lower dose than prescribed, which may affect the management of their medical condition.

Risk

A patient unknowingly taking a 5mg tablet instead of their prescribed 10mg dose may experience a decrease in the effectiveness of their treatment. No injuries or adverse events have been reported in connection with this recall.

What You Should Do

  1. Check your medication bottle for the product name Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg (100-count bottle).
  2. Look for NDC 0527-0762-37 and Lot number 25283185A with an expiration date of 02/28/2027.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (100-count)
Variants: 10mg, Tablet
Lot Numbers:
25283185A (Exp 02/28/2027)
NDC:
0527-0762-37

Recall #: D-0642-2025; Distributed by Lannett Company, Inc., Philadelphia, PA 19136.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97461
Status: Resolved
Manufacturer: Lannett Company Inc.
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 4,848 bottles
Distributed To: Ohio
Agency Last Updated: September 11, 2025

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.